Simplex Trading
ITCI

Simplex Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Simplex Trading’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,700
Closed -$1.39M – 9961
2024
Q4 		$1.39M Sell
16,700
-200
-1% -$16.4K ﹤0.01% 2535
2024
Q3 		$1.24M Sell
16,900
-11,300
-40% -$849K ﹤0.01% 2715
2024
Q2 		$1.93M Sell
28,200
-61,200
-68% -$4.24M ﹤0.01% 2234
2024
Q1 		$6.19M Buy
89,400
+66,900
+297% +$4.6M ﹤0.01% 1445
2023
Q4 		$1.61M Buy
22,500
+14,200
+171% +$817K ﹤0.01% 2546
2023
Q3 		$432K Buy
8,300
+6,400
+337% +$373K ﹤0.01% 3565
2023
Q2 		$120K Sell
1,900
-46,100
-96% -$2.87M ﹤0.01% 4864
2023
Q1 		$2.6M Buy
48,000
+11,800
+33% +$571K ﹤0.01% 1729
2022
Q4 		$1.92M Hold
36,200
– – ﹤0.01% 1899
2022
Q3 		$1.68M Buy
36,200
+30,800
+570% +$1.61M ﹤0.01% 2110
2022
Q2 		$308K Sell
5,400
-8,000
-60% -$454K ﹤0.01% 4071
2022
Q1 		$819K Sell
13,400
-10,700
-44% -$556K ﹤0.01% 3158
2021
Q4 		$1.26M Buy
24,100
+12,100
+101% +$508K ﹤0.01% 2557
2021
Q3 		$509K Hold
12,000
– – ﹤0.01% 4090
2021
Q2 		$489K Buy
12,000
+11,839
+7,353% +$438K ﹤0.01% 4208
2021
Q1 		$546K Sell
161
-77
-32% -$2.67K ﹤0.01% 3243
2020
Q4 		$756K Sell
238
-326
-58% -$8.57K ﹤0.01% 2910
2020
Q3 		$1.45M Buy
564
+34
+6% +$776 ﹤0.01% 1847
2020
Q2 		$1.36M Sell
530
-19
-3% -$385 ﹤0.01% 1851
2020
Q1 		$843K Sell
549
-4,145
-88% -$90K ﹤0.01% 2037
2019
Q4 		$16.1M Buy
4,694
+3,670
+358% +$44K 0.04% 330
2019
Q3 		$764K Buy
1,024
+370
+57% +$3.55K ﹤0.01% 2208
2019
Q2 		$848K Buy
654
+428
+189% +$5.49K ﹤0.01% 2057
2019
Q1 		$275K Buy
226
+61
+37% +$779 ﹤0.01% 3270
2018
Q4 		$187K Buy
165
+106
+180% +$1.71K ﹤0.01% 3226
2018
Q3 		$128K Sell
59
-489
-89% -$10.2K ﹤0.01% 4167
2018
Q2 		$968K Sell
548
-170
-24% -$3.45K ﹤0.01% 1824
2018
Q1 		$64K Buy
718
+539
+301% +$10.5K ﹤0.01% 2190
2017
Q4 		$28K Sell
179
-260
-59% -$4.01K ﹤0.01% 3004
2017
Q3 		$43K Buy
439
+367
+510% +$5.38K ﹤0.01% 2450
2017
Q2 		$8K Buy
72
+36
+100% +$417 ﹤0.01% 4216
2017
Q1 		$43K Sell
36
-122
-77% -$1.77K ﹤0.01% 2519
2016
Q4 		$87K Sell
158
-1,088
-87% -$15.4K 0.01% 1653
2016
Q3 		$1.16M Buy
1,246
+1,010
+428% +$40.8K 0.08% 219
2016
Q2 		$120K Buy
236
+104
+79% +$3.74K 0.01% 1351
2016
Q1 		$283K Sell
132
-29
-18% -$966 0.02% 692
2015
Q4 		$84K Sell
161
-120
-43% -$6.05K 0.01% 1496
2015
Q3 		$170K Buy
+281
New +$9.16K 0.01% 1023

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Simplex Trading's ITCI Position: Q2 2025 in Review

Simplex Trading sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 3,214 shares — an estimated $423K sold.

Simplex Trading first reported a position in ITCI in Q3 2015 and held it in 27 quarters. The position peaked at $2.29M in Q1 2023. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Simplex Trading reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 3,214 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $423K.
  • Simplex Trading first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 27 quarters.
  • Simplex Trading's Intra-Cellular Therapies Inc. position peaked at $2.29M in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.